NEW JERSEY ALLIANCE FOR
CLINICAL AND TRANSLATIONAL SCIENCE


NEWS, EVENTS, and DEADLINES
November 23, 2021
Upcoming NJ ACTS and Rutgers Events
Princeton’s Innovation and Entrepreneurship Conference

Join fellow innovators to make connections and discover your own opportunities – through industry intersections, entrepreneurship, transformational research and Princeton's leadership of the regional innovation ecosystem.

ENGAGE 2021 is open to all. There is no fee to attend

December 1-2, 2021

NJ ACTS Workforce Core invites you to the
Clinical and Translational Science Intern Symposium

After working intensely with members of the NJ ACTS core leads, they have networked with trainees/clinicians/scientists, learned about NJ ACTS, and now they are all excited to share their experiences, and provide insight into their final project deliverables.

All interested Students, Faculty, and Staff are invited to attend!  

December 2, 2021
5 - 9 pm

Research Resources Workshop
Wednesday Series

Rutgers University Libraries
Consuella Askew, EdD
Interim Vice President for University Libraries and University Librarian


December 8, 2021
4 - 5 pm
Enabling Protein Structure Prediction with AI
at Rutgers and Beyond


The Institute of Quantitative Biology in collaboration with the Office of Advanced Research Computing and the Office for Research offers a crash course on "Enabling Protein Structure Prediction with Artificial Intelligence at Rutgers and Beyond."

The course will present a broad overview of how Artificial Intelligence/Machine Learning (AI/ML) methods are being used for de novo protein structure prediction and hands-on experience with the state-of-the-art AI methods - AlphaFold2 and RoseTTAFold.


December 9, 2021 
1 - 5 pm 



...and More Events of Interest
N3C Orientation

Session A

This session provides a general overview of N3C, introduces the three data tiers available and important considerations for research driven by the data harmonization process, and discusses resources for training and help, as well as the Data Use Request (DUR) process required for researcher access.

November 23, 2021
11 am - 12:30 pm

University of North Carolina Clinical Science Institute is hosting the
TL1 William Schnaper Visiting Scientist Program Event


Neutralizing Antibody Suppression:
Overcoming a Natural Barrier to Viral Vectored Gene Therapies


Charlie Askew, Post Doctoral Fellow
UNC Gene Therapy Center

November 29, 2021
9 - 9:45 am
‌
NEWS
Is Architecture the Ultimate Team Sport? And, if so, what Lessons can be Applied to Biomedical Research?  
 
What do the tallest building in New Jersey, the Honors Dorm at Rutgers, the Camden School of Nursing and Sciences Building and the RWJBarnabas Health Facility have in common? These buildings, as well as countless others, are the result of the design, organizational and management skills of the teams from Perkins Eastman Architects.  
 
Bradford Perkins, Co-founder and Chair, Nick Leahy, Co-CEO and Executive Director, and Rachel Birnboim, Associate Principal and Senior Project Manager of Perkins Eastman Architects recently spoke with Biju Parekkadan, PhD, Co-lead of the NJ ACTS Team Science Core as part its seminar series, The Team Science Core Presents Secrets of Successful Teamwork: What Can Academia Learn from Non-Academia? 
 
Mixing case studies of three projects, each of which presented different challenges, requiring specific and different sets of skills, the seminar concentrated on lessons about what makes for successful teams. These lessons are as applicable to biomedical research as to architecture and building, and should be taken to heart by team leaders and members, alike. 
 
Spotlight on Translational Research:
Rutgers Translational Research Facility Planned 

The importance of our translational research mission is reflected in the recent announcement that a new Rutgers Translational Research facility will be built in New Brunswick in the NJ Innovation and Technology Hub. The HUB is designed to foster the growth of start-up companies and new technologies in a range of industries and to support the translation of research into real-world applications enabling new ventures to grow and expand the New Jersey economy. The HUB’s expansion to include the Rutgers Translational Research Facility and the new academic building for the Rutgers Robert Wood Johnson Medical School provides increased collaborative opportunities for researchers, clinicians, biologists and members of the pharmaceutical industry to work together to pursue new therapies.  

NJMS Inventors Receive 2021 Edison Patent Award
in Biotechnology 
 
NJ ACTS congratulates New Jersey Medical School faculty members, Michael G. Dunn, PhD, Charles J. Gatt, Jr., MD, and Eric A. Balint, PhD, on receiving the 2021 Thomas Edison Patent Award in Biotechnology for their invention, “Bioresorbable Tissue Engineered Fibrocartilage Replacement with Three-Dimensional Matrix of Fibers.” The Thomas Edison Patent Awards, currently in the 42nd year, recognize and highlight the broad array of research conducted in New Jersey. Winners are selected by a team of The Research and Development Council of New Jersey who evaluate nominated patents based on the significance of the problem addressed, its utility/socioeconomic value, novelty and commercial impact. The absorbable implant to treat meniscal tears reduces stress on knee cartilage and induces the formation of functional neo-meniscus tissue, restoring knee mobility and potentially preventing the development of osteoarthritis after severe meniscus injury. The patent has been exclusively licensed by NovoPedics, Inc. which is currently performing preclinical studies on the patented device, trademarked as MeniscoFixTM. 
Episode 3:
What to Expect this Holiday Season

Host:
Mary Marchetta O'Dowd, MPH
Executive Director, Health Systems and Population Health Integration
Rutgers Biomedical and Health Sciences

Guest:
Perry Halkitis, PhD, MS, MPH
Dean, School of Public Health
Listen on : APPLE, SPOTIFY, GOOGLE, ANCHOR, RADIO PUBLIC

DEADLINES

  • Pfizer Quality Improvement Grant RFP Equity in Access to Rare Disease Clinical Trials - Deadline 12/2 - View RFP


NJ ACTS Publications

Geographic diversity in authorship of HIV randomized control trial publications. Wang P, McGovern M, Togo Y. AIDS. 2021 Nov 15;35(14):2407-2409.

Racial-ethnic inequality in cardiovascular health in the United States: Does it mirror socioeconomic inequality? Teitler J, Wood BM, Zeng W, Martinson ML, Plaza R, Reichman NE. Ann Epidemiol. 2021 Oct;62:84-91. Epub 2021 May 13.

In Case You Missed IT


NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
Components